Driver assessment, communication with pharmacists

Issue: BCMJ, vol. 53 , No. 4 , May 2011 , Pages 163 Letters

Thank you for publishing Dr Laycock’s review of the un­certainties inherent in the current methods used in driver assessment (BCMJ 2011;53:74-78). I agreed with his position in a letter I wrote to Canadian Family Physician (“Doctors should not evaluate competence to drive,” 2011;57:170).

On a different topic, I am following a middle-aged patient whose kidney function is declining rapidly. In October the eGFR was 27 ml/minute. Last month the patient went to a walk-in clinic complaining of gout. The doctor prescribed naproxen 500 mg X 30, 1 p.o. t.i.d. A pharmacy issued the tablets. The patient’s next eGFR was lower than 27 ml/minute.

The nephro­logist was disappointed that the pa­tient had been prescribed an NSAID. I called the pharmacist who issued the naproxen. She said, “Our staff did not know what the patient’s eGFR was.” Two other pharmacists have confirm­ed that they usually do not know about the status of a patient’s kidneys or liver, and that they would appreciate knowing why a drug is being prescribed. For example, is ramipril be­ing prescribed to treat arterial hypertension, congestive heart failure, or diabetic nephropathy? The pharmacist can counsel the pa­tient better if he or she knows about a patient’s medical conditions.

I suggest that we write the indication for the medication on the prescription sheet. If it is the first time you are communicating with a pharmacy, also indicate the patient’s important medical conditions, allergies, the creatinine or eGFR, and the hepatic transferases (if the lab results are abnormal).
—Robert Shepherd, MD
Victoria

Robert Shepherd, MD. Driver assessment, communication with pharmacists. BCMJ, Vol. 53, No. 4, May, 2011, Page(s) 163 - Letters.



Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply